Trial intelligence / Profile preview

Surgical vs Medical Abortion for Early Pregnancy Loss on Sexual Function

NCT07646275Completed

Sponsor
Harran University
Start
Apr 2025
Primary completion
Jan 2026
Countries
1
01

Overview

Open-label trial of mifepristone and misoprostol in early pregnancy loss (EPL) (2 arms), sponsored by Harran University. Primary endpoint: Female Sexual Function Index Total Score at 6 months. Started Apr 2025; status: completed.

02

Drugs

mifepristonemisoprostol
03

Conditions

early pregnancy loss (EPL)

Beyond the preview

Go deeper on NCT07646275.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07646275.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call